Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702570 | Urologic Oncology: Seminars and Original Investigations | 2017 | 13 Pages |
Abstract
The involvement of the KYN pathway enzymes and catabolites in ccRCC occurs via both immune and nonimmune mechanisms. Our data suggest that KTR could serve as a marker of ccRCC aggressiveness and as a prognostic factor for CSS and PFS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Giuseppe M.D., Ph.D., Monica Ph.D., Matteo M.D., Andrea Ph.D., Angelica Ph.D., Francesco Ph.D., Silvano M.D., Margherita Ph.D., Giuseppe M.D., Elena Ph.D., Carlo M.D., Daniela Ph.D., Francesca M.D., Anna M.D., Eugenio M.D., Franco M.D., Pasquale M.D.,